BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1135620)

  • 1. The handling of indocyanine green by the liver.
    Paumgartner G
    Schweiz Med Wochenschr; 1975; 105(17 Suppl):1-30. PubMed ID: 1135620
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of indocyanine green on bile flow and bile salt excretion.
    Horak W; Grabner G; Paumgartner G
    Helv Med Acta; 1973 Sep; 37(2):169-74. PubMed ID: 4748926
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma disappearance of sulfobromophthalein or indocyanine green in unconjugated hyperbilirubinemia.
    Yeary RA; Wise KJ
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):125-36. PubMed ID: 1188179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
    Sathirakul K; Suzuki H; Yasuda K; Hanano M; Tagaya O; Horie T; Sugiyama Y
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bile salt-independent bile formation by indocyanine green.
    Horak W; Grabner G; Paumgartner G
    Gastroenterology; 1973 May; 64(5):1005-12. PubMed ID: 4700412
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance.
    Klaassen CD; Plaa GL
    J Pharmacol Exp Ther; 1968 Jun; 161(2):361-6. PubMed ID: 5650142
    [No Abstract]   [Full Text] [Related]  

  • 8. Indocyanine green plasma clearance in normal human males and females.
    Mikulecký M
    Acta Med Acad Sci Hung; 1976; 33(2):133-41. PubMed ID: 1030567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of indocyanine green clearance by means of dichromatic ear densitometry for evaluation of liver function].
    Paumgartner G; Longueville J; Leevy CM
    Wien Z Inn Med; 1967; 48(6):227-35. PubMed ID: 5620283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chromodiagnosis of the liver: interpretation of the elimination curve of indocyanine green dye (Wofaverdin)].
    Seifert A; Ehrke D; Balzer H
    Z Gesamte Inn Med; 1968 Sep; 23(17):527-31. PubMed ID: 5728034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Different elimination velocity of indocyanine green in liver diseases of various severity].
    Brügmann E
    Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation and metabolism of indocyanine green: high-pressure liquid chromatographic analysis.
    Igarashi H; Kamisaka K; Maezawa H; Uesugi T
    Bull Tokyo Med Dent Univ; 1990 Dec; 37(4):59-69. PubMed ID: 2091869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine cases with marked retention of indocyanine green test and normal sulfobromophthalein test without abnormal liver histology: constitutional indocyanine green excretory defect.
    Namihisa T; Nambu M; Kobayashi N; Kuroda H
    Hepatogastroenterology; 1981 Feb; 28(1):6-12. PubMed ID: 7216141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of liver function by means of the glucagon test].
    Brunner H; Grabner G; Michalek P; Paumgartner G
    Wien Z Inn Med; 1968; 49(11):409-17. PubMed ID: 5737590
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatobiliary transport of indocyanine green and sulfobromophthalein in fed and fasted horses.
    Engelking LR; Anwer MS; Lofstedt J
    Am J Vet Res; 1985 Nov; 46(11):2278-84. PubMed ID: 4073638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excretion rate of indocyanine green in liver diseases of various severity].
    Teichmann W; Brügmann E; Schulz H
    Orv Hetil; 1973 May; 114(20):1170-1. PubMed ID: 4704298
    [No Abstract]   [Full Text] [Related]  

  • 19. The adaptive identification and simulation of the hepatobiliary transport and storage of intravenously injected indocyanine green.
    Mikulecký M; Deik L
    Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):203-7. PubMed ID: 665121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of probenecid on indocyanine green clearance.
    Vogin EE; Scott W; Boyd J; Bear WT; Mattis PA
    J Pharmacol Exp Ther; 1966 Jun; 152(3):509-15. PubMed ID: 5922315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.